Navigation Links
Valeant Pharmaceuticals Reports 2012 Fourth Quarter Financial Results
Date:2/28/2013

MONTREAL, Feb. 28, 2013 /PRNewswire/ -- 

Fourth Quarter 2012

  • 2012 Fourth Quarter Total Revenue $986 million; an increase of 43% over the prior year
  • Organic growth (same store sales) was approximately 7%
  • Pro forma organic growth was approximately 9%
  • 2012 Fourth Quarter GAAP EPS Loss of $0.29; Cash EPS $1.22, an increase of 30% over the prior year;
  • Excluding Medicis interest expense Cash EPS $1.34, an increase of 43% over the prior year
  • 2012 Fourth Quarter GAAP Operating Cash Flow $68 million; Adjusted Operating Cash Flow $423 million 
  • Full Year 2012

  • Total 2012 revenue was $3.55 billion; an increase of 44% over the prior year
  • Organic growth (same store sales) was approximately 8%
  • Pro forma organic growth was approximately 10%
  • Total 2012 GAAP EPS Loss of $0.38; Cash EPS $4.51, an increase of 54% over the prior year
  • Total 2012 GAAP Operating Cash Flow $657 million; Adjusted Operating Cash Flow $1.3 billion
  • Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announces fourth quarter financial results for 2012.

    "We are pleased with our financial results for the fourth quarter and the full year," said J. Michael Pearson, chairman and chief executive officer. "The continued overall robust organic growth of our business, coupled with our strong cash flow generation, puts us in a solid position for another outstanding year in 2013."

    RevenueValeant's business continued to perform well in the fourth quarter of 2012 with all businesses achieving results at or above expectations. Same store organic growth was approximately 7% and pro forma organic growth was approximately 9% for the fourth quarter of 2012. (See Table 6) Total revenue was $986 million in the fourth quarter of 2012, as compared to $688 million in the fourth q
    '/>"/>

    SOURCE Valeant Pharmaceuticals International, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

    Related medicine technology :

    1. Valeant Completes Acquisition Of Natur Produkt In Russia
    2. Valeant Pharmaceuticals To Announce 2012 Fourth Quarter Results On February 28, 2013
    3. Valeant Completes Acquisition of Medicis and Announces Date of 2013 Financial Guidance Conference Call
    4. Valeant Pharmaceuticals And Galderma Agree On Revised Agreement Terms
    5. Valeant Pharmaceuticals Announces New Management Appointments
    6. Valeant Pharmaceuticals Announces Publication of Efinaconazole Phase III Results
    7. Valeant Pharmaceuticals Annonces New $1.5 Billion Securites Repurchase Program
    8. Valeant Pharmaceuticals Receives FTC Clearance For Medicis Acquisition
    9. Valeant Pharmaceuticals Reports 2012 Third Quarter Financial Results
    10. Valeant Pharmaceuticals Reschedules Its Third Quarter 2012 Financial Results Webcast And Conference Call To November 2, 2012 Due To Hurricane Sandy
    11. Valeant Pharmaceuticals International, Inc. Announces Pricing Of Concurrent Private Offerings Of Senior Notes
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/28/2014)...  In recognition of the increased risks that ... flu, pneumonia, shingles and other illnesses, CVS/pharmacy ® ... to be Senior Vaccination Month. Because people,s immune ... that adults ages 65 years and older stay ... and MinuteClinic nurse practitioners and physician assistants will ...
    (Date:8/28/2014)... , Aug. 28, 2014 /PRNewswire/ ... market research report is available in ... Therapeutics in Asia-Pacific Markets to 2020 ... Unmet Need in Newly Diagnosed and ... http://www.reportlinker.com/p02343492/Glioblastoma-Multiforme-Therapeutics-in-Asia-Pacific-Markets-to-2020---Novel-Therapeutic-Approaches-Target-High-Unmet-Need-in-Newly-Diagnosed-and-Recurrent-GBM.html Glioblastoma ...
    (Date:8/28/2014)... , Aug. 28, 2014 Telik, Inc. (OTCQB: ... that merged with MabVax Therapeutics, Inc. on July ... progress related to the development of its lead ... recovered using the Company,s internally developed antibody discovery ... for multiple antibody based therapeutic and diagnostic products ...
    Breaking Medicine Technology:September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 2September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 3September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 4Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 2Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 3Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 4Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 5Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 6Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 7Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 8Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 9Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 2Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 3Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 4
    ... report is available in its catalogue: , , , ... , , http://www.reportlinker.com/p0191978/China-Patient-Monitoring-Market-Outlook-to-2016.html ... China Patient Monitoring Market Outlook to 2016 , , , ... , , "China Patient Monitoring Market Outlook ...
    ... June 1 Clinicians at Institut Catala d,Oncologia (ICO) in ... using RapidArc® radiotherapy from Varian Medical Systems (NYSE: VAR). A 73-year-old prostate ... the country to receive the fast and efficient treatment. , ... "The treatment went very well and the ...
    Cached Medicine Technology:Reportlinker Adds China Patient Monitoring Market Outlook to 2016 2Reportlinker Adds China Patient Monitoring Market Outlook to 2016 3Reportlinker Adds China Patient Monitoring Market Outlook to 2016 4Reportlinker Adds China Patient Monitoring Market Outlook to 2016 5Reportlinker Adds China Patient Monitoring Market Outlook to 2016 6Reportlinker Adds China Patient Monitoring Market Outlook to 2016 7Reportlinker Adds China Patient Monitoring Market Outlook to 2016 8Reportlinker Adds China Patient Monitoring Market Outlook to 2016 9Reportlinker Adds China Patient Monitoring Market Outlook to 2016 10Reportlinker Adds China Patient Monitoring Market Outlook to 2016 11Reportlinker Adds China Patient Monitoring Market Outlook to 2016 12Reportlinker Adds China Patient Monitoring Market Outlook to 2016 13Reportlinker Adds China Patient Monitoring Market Outlook to 2016 14Reportlinker Adds China Patient Monitoring Market Outlook to 2016 15Reportlinker Adds China Patient Monitoring Market Outlook to 2016 16Reportlinker Adds China Patient Monitoring Market Outlook to 2016 17Reportlinker Adds China Patient Monitoring Market Outlook to 2016 18Reportlinker Adds China Patient Monitoring Market Outlook to 2016 19Reportlinker Adds China Patient Monitoring Market Outlook to 2016 20Reportlinker Adds China Patient Monitoring Market Outlook to 2016 21Reportlinker Adds China Patient Monitoring Market Outlook to 2016 22Reportlinker Adds China Patient Monitoring Market Outlook to 2016 23Reportlinker Adds China Patient Monitoring Market Outlook to 2016 24Prostate Cancer Patient First in Spain to Receive Fast and Precise RapidArc(R) Radiotherapy Treatment from Varian 2Prostate Cancer Patient First in Spain to Receive Fast and Precise RapidArc(R) Radiotherapy Treatment from Varian 3Prostate Cancer Patient First in Spain to Receive Fast and Precise RapidArc(R) Radiotherapy Treatment from Varian 4
    (Date:8/28/2014)... August 28, 2014 Gurnick Academy of ... Technology program is re-accredited for the 5 years of ... Imaging Technologists (ARMRIT). , “We are very proud ... improving our program to make sure we provide the ... of interest in MRI field nowadays and I look ...
    (Date:8/28/2014)... Amy Norton HealthDay Reporter ... have found that sending electrical currents through the scalp to ... for up to a day. In a small study ... to fire up certain networks involved in memory. That, in ... apparent 24 hours after the brain stimulation. During TMS, ...
    (Date:8/28/2014)... "stuck fermentation," when yeast that should be busily converting ... down, leaving the remaining sugar to instead be consumed ... team of researchers including UC Davis yeast geneticist Linda ... problem. Working through a prion -- an abnormally ... enables bacteria in fermenting wine to switch yeast from ...
    (Date:8/28/2014)... August 28, 2014 Data from the ... that while most hospitals utilize a basic electronic health ... information technology is still a challenge. , This ... August issue of Health Affairs , and is co-authored ... Care Data Center, as well as Chantal Worzala, director ...
    (Date:8/28/2014)... Tenn. The New England Journal of Medicine ... clinical trial of a drug shown to safely reduce ... volunteers intranasally infected with respiratory syncytial virus (RSV). ... of Tennessee Health Science Center researcher Infectious Disease Specialist ... , RSV is the most common cause ...
    Breaking Medicine News(10 mins):Health News:Gurnick Academy’s MRI Program Is Re-Accredited by ARMRIT for the 5 Years 2Health News:Electrical Pulses to Scalp May Boost Memory: Study 2Health News:Electrical Pulses to Scalp May Boost Memory: Study 3Health News:Prions can trigger 'stuck' wine fermentations, researchers find 2Health News:AHA Data Shows Progress, Challenges on Road to Healthcare IT Adoption 2Health News:AHA Data Shows Progress, Challenges on Road to Healthcare IT Adoption 3Health News:DeVincenzo study breakthrough in RSV research 2
    ... is serving up a surprise not only for tomato lovers ... rod-shaped bacterium that causes misery for millions of people. , ... PloS One , researchers say they,ve identified a molecular trick ... from the University of Rochester Medical Center has identified a ...
    ... has entered,into a binding agreement to purchase the ... MSC, which previously consisted of two,distinct units -- ... brand and,all employees, products and services not associated ... ESRX ) is one of the largest ...
    ... days to try to resolve remaining issues, TORONTO, ... PMD; Amex: PME) today announced that the Company has ... (FDA) in an,effort to resolve the outstanding issues associated ... test. Over the,next 60 days PreMD and the FDA ...
    ... research shows , , FRIDAY, June 13 (HealthDay News) -- ... the morning may help ease some stresses you might ... rats inhaled the aroma of roasted coffee beans, a ... proteins with healthful antioxidant activity, the researchers reported. ...
    ... June 13 The Blinded,American Veterans Foundation (BAVF), at ... Maryland State Delegate Sheila Hixson., "We,re honored to ... of Maryland,s District 20 and to the entire State ... MD. "Her,tireless efforts as a legislator and community activist ...
    ... more reliable detection of Chlamydia trachomatis, the most ... disease in Europe., PLEASANTON, Calif., June 13 ... Chlamydia trachomatis has received CE Mark,certification, allowing it to ... is designed with a dual target approach to help ...
    Cached Medicine News:Health News:Salmonella: Trickier than we imagined 2Health News:Salmonella: Trickier than we imagined 3Health News:Express Scripts in Binding Agreement with MSC for the Purchase of its Pharmacy Services Division 2Health News:Express Scripts in Binding Agreement with MSC for the Purchase of its Pharmacy Services Division 3Health News:PreMD Reports Further Positive Meetings with the FDA 2Health News:Coffee Beans May Be Newest Stress-Buster 2Health News:Coffee Beans May Be Newest Stress-Buster 3Health News:Blinded Vets Foundation to Honor Maryland State Delegate Sheila Hixson 2Health News:New Roche Chlamydia Test Approved for Use in European Union 2Health News:New Roche Chlamydia Test Approved for Use in European Union 3
    Stryker bariatric laparoscopes set the standard in picture quality....
    The flexible nature of the vinyl allows the user to reach deeper into the chamber and allows for a greater comfort when working inside the glove box over a long period of time compared to any rigid s...
    Compact, economical Bactron II anaerobic environment system with air lock, workspace and a 200 plate capacity incubator delivers optimum productivity in a compact space....
    ... Bactron I is an ... designed for use by smaller ... as an economical set-up station ... quality features of other Bactron ...
    Medicine Products: